Laboratory Payer Feasibility and Medical-Necessity Checklists
Laboratories are facing increasing reimbursement pressure across molecular and diagnostic testing, including UTI, respiratory, toxicology, pharmacogenomics and genetic testing.
Having an FDA-cleared or authorized assay and a valid CPT code does not guarantee coverage or payment.
Payers are increasingly examining whether the test was appropriate for the individual patient, whether the clinical documentation supports the service, and whether the billing and contracting requirements were met.
Payers may consider:
Whether the patient had documented symptoms, diagnoses or risk factors
Why the physician selected that particular test
Whether a smaller panel or conventional test was appropriate
Whether previous testing and frequency limitations were reviewed
How the result was expected to affect patient management
Whether the laboratory was in network
Whether prior authorization was required
Whether the patient was in a Medicare Part A SNF stay
Whether the service was related to a hospice terminal diagnosis
For laboratory owners, executives, compliance teams and sales representatives, these considerations should be evaluated before investing in a new assay, promoting a test or scaling testing volume.
To help organizations evaluate these issues, J JOHN Consulting has developed two practical resources.
Resource 1: State-Specific Payer Feasibility Checklists
Separate payer-feasibility workbooks are available for:
Texas
Florida
New Jersey
Georgia
California
Alabama
Each workbook is designed to help laboratories evaluate potential assays against the reimbursement environment in the applicable state.
What Is Included?
Medicare Jurisdiction
Identify the Medicare Administrative Contractor (MAC) responsible for processing claims in the state.
MolDX Requirements
Determine whether MolDX may apply and whether the assay may require test registration, DEX participation, a Z-code, or compliance with a specific LCD or billing article.
Regional and National Payers
Evaluate Medicare Advantage, commercial insurance, regional Blue Cross and Blue Shield plans, Medicaid and managed Medicaid considerations.
SNF and Hospice Billing
Identify whether the test may be separately billable or whether payment considerations may involve a skilled nursing facility or hospice contract.
Payer-by-Test Analysis
Review more than 200 payer-and-test combinations using an editable feasibility matrix.
The matrix considers:
Coverage indication
Prior-authorization requirements
Network status
Expected allowed amount
Medical-necessity strength
Administrative difficulty
Collection confidence
Legitimate patient demand
Compliance exposure
GO–PILOT–HOLD Scoring
Each opportunity can be classified as:
GO
A potentially strong opportunity after final policy and contract verification.
PILOT
Test a limited number of properly documented claims before investing or scaling.
HOLD
Do not invest until major coverage, coding, clinical or contracting concerns are resolved.
This approach helps separate a promising testing opportunity from one that may create avoidable reimbursement or compliance risk.
Resource 2: Physician Medical-Necessity Ordering Checklist
The physician checklist is designed to support appropriate, patient-specific ordering.
It does not tell physicians how to make patients "qualify" for testing.
Instead, it helps the ordering provider document the clinical facts that explain why a particular test is appropriate for that patient.
The Checklist Covers
When each test may be considered
Relevant symptoms, diagnoses, exposures and risk factors
Appropriate specimen and collection requirements
Clinical exclusions and alternative explanations
Previous testing and frequency limitations
Repeat-testing and test-of-cure restrictions
How the result is expected to change patient care
Payer, network and authorization verification
Medicare Part A SNF and hospice billing considerations
Tests Included
The resources address potential opportunities and considerations involving tests such as:
C. difficile NAAT
Focused gastrointestinal pathogen panels
H. pylori stool antigen
Procalcitonin
Urine albumin-to-creatinine ratio
Cystatin C
BNP and NT-proBNP
HbA1c
TB interferon-gamma release assays
FIT colorectal cancer screening
Multitarget stool DNA screening
Selected MRSA testing
Fecal calprotectin
Legionella urinary antigen
Pneumococcal urinary antigen
Aspergillus galactomannan
Emerging Alzheimer’s biomarkers
Selected wound-testing considerations
Patient-Specific Order Documentation Form
The workbook includes an editable form designed to capture the information needed to support an appropriate, patient-specific testing decision.
The form captures:
Patient and facility information
Place of service
SNF Part A and hospice status
Test requested
Symptoms and date of onset
Relevant diagnoses and risk factors
Specimen type
Previous test results and dates
Medications or treatments that may affect the result
Contraindications and exclusions
Intended action following a positive or negative result
Physician attestation and supporting documentation
The form begins in a HOLD status and changes only after the required documentation elements have been completed.
When Should a Test Be Offered?
A laboratory test should generally be considered when:
1. The patient has a documented symptom, diagnosis, exposure or recognized risk.
2. The test is appropriate for the patient's clinical presentation.
3. The specimen and testing methodology match the assay's intended use.
4. Relevant exclusions and alternative explanations have been considered.
5. Previous tests and applicable frequency limitations have been reviewed.
6. The ordering physician can explain how the result is expected to affect treatment, isolation, referral, monitoring or another clinical decision.
7. The payer's coverage, network and authorization requirements have been checked.
8. The appropriate billing route has been established for SNF and hospice patients.
Testing should not be driven simply by facility census, payer type or the availability of a specimen.
The clinical decision to order a test should remain with the treating provider.
How Laboratory Sales Teams Should Use These Resources
Laboratory representatives should educate providers about:
The assay's intended clinical use
Appropriate patient selection
Specimen requirements
Known limitations
Repeat-testing restrictions
Expected turnaround time
How results can support patient management
Available payer policies and authorization requirements
Sales representatives should never select diagnoses, create symptoms, complete clinical documentation for the physician or encourage standing orders based only on patient age or facility residency.
The decision to order the test must remain with the treating provider.
Who Should Use These Checklists?
These resources are designed for:
Independent laboratory owners
Laboratory executives
Medical directors
Compliance officers
Revenue cycle and billing teams
Molecular laboratory sales teams
Skilled nursing facility partners
Hospice laboratory partners
Physician practices evaluating new assays
Investors conducting laboratory due diligence
Download the ChecklistsChoose the state-specific payer checklist that matches your laboratory's billing location.
Download Texas Payer Feasibility ChecklistDownload Florida Payer Feasibility ChecklistDownload New Jersey Payer Feasibility ChecklistDownload Georgia Payer Feasibility ChecklistDownload California Payer Feasibility ChecklistDownload Alabama Payer Feasibility ChecklistDownload Physician Medical-Necessity Ordering ChecklistNeed a Customized Laboratory Feasibility Review?
A spreadsheet is a starting point.
The final decision should be based on your laboratory's specific:
• Billing location
• Test menu
• Exact assay and methodology
• CLIA capabilities
• Medicare MAC
• Payer contracts
• Network participation
• Historical reimbursement
• Denial and appeal experience
• Facility relationships
• Expected patient population
J JOHN Consulting can help laboratories evaluate new testing opportunities, reimbursement risk, payer policies, documentation workflows and go-to-market strategy.
Request a Laboratory Feasibility Consultation
Visit jjohnconsulting.com to learn more about J JOHN Consulting's healthcare operations and revenue cycle consulting services.
Important Notice
These materials are intended for general educational, operational and compliance-planning purposes. They do not constitute medical, legal, coding or reimbursement advice.
Coverage and payment depend on the individual patient, treating provider's documentation, exact assay, CPT or HCPCS reporting, payer policy, member benefit, network status, contract terms, Medicare jurisdiction and applicable federal and state requirements.
FDA clearance or authorization and the existence of a CPT code do not guarantee coverage or payment.
Payer policies, coverage requirements and clinical guidelines can change frequently. Users should verify current requirements before ordering, performing or billing any test.
